Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    3166511 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Intervention: Drug: indinavir (MK-0639)

Indicates status has not been verified in more than two years